P PHARMALYS LABORATORIES Trademark

Trademark Overview


On Friday, September 19, 2025, a trademark application was filed for P PHARMALYS LABORATORIES with the United States Patent and Trademark Office. The USPTO has given the P PHARMALYS LABORATORIES trademark a serial number of 79443192. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Thursday, February 19, 2026. This trademark is owned by Pharmalys Laboratories SA. The P PHARMALYS LABORATORIES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products; sanitary products for medicine; dietetic substances and foodstuffs for medical use; food for babies; food supplements for human beings; powdered milk for babies; milk of almonds for pharmaceutical use; malted milk for medical use; galactagogue preparations; lactose for pharmaceutical use; galactagogues; food for infants; beverages used as dietary supplements; dietetic beverages for medical use; beverages for diabetics based on fruit juices for medical use; powdered fruit-flavored mixtures for beverages for use as dietary supplements; beverages enriched with vitamins for medical use; nutritional mixtures in the form of beverages used as meal replacements; nutritional supplement mixtures for beverages in the form of powders; preparations for making medicated beverages; dietetic food supplements; dietetic substances consisting of vitamins, minerals, amino acids and trace elements; powdered almond milk for preparation of beverages for bottle feeding of young childr...
p pharmalys laboratories

General Information


Serial Number79443192
Word MarkP PHARMALYS LABORATORIES
Filing DateFriday, September 19, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateThursday, February 19, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products; sanitary products for medicine; dietetic substances and foodstuffs for medical use; food for babies; food supplements for human beings; powdered milk for babies; milk of almonds for pharmaceutical use; malted milk for medical use; galactagogue preparations; lactose for pharmaceutical use; galactagogues; food for infants; beverages used as dietary supplements; dietetic beverages for medical use; beverages for diabetics based on fruit juices for medical use; powdered fruit-flavored mixtures for beverages for use as dietary supplements; beverages enriched with vitamins for medical use; nutritional mixtures in the form of beverages used as meal replacements; nutritional supplement mixtures for beverages in the form of powders; preparations for making medicated beverages; dietetic food supplements; dietetic substances consisting of vitamins, minerals, amino acids and trace elements; powdered almond milk for preparation of beverages for bottle feeding of young children.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 12, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmalys Laboratories SA
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, February 12, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 17, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 17, 2026APPLICATION FILING RECEIPT MAILED
Wednesday, February 18, 2026ASSIGNED TO EXAMINER
Thursday, February 19, 2026NON-FINAL ACTION WRITTEN
Friday, February 20, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW